The global hemodialysis and peritoneal dialysis market size was valued at USD 60.6 billion in 2015 and is expected to grow with CAGR of 6.0% over the forecast period. Rising incidence of kidney failure and chronic renal dysfunction is expected to promote the market growth over the forecast period.
According to statistics by the National Kidney Foundation, as of 2014, there are more than 2.0 million people across the globe suffering from chronic kidney failure who are currently undergoing dialysis treatment. It is an alternative treatment provided until the patients gain a donor and have a successful renal transplantation. Even though the transplant percentages are rising each year, the dialysis rate is subsequently constant, owing to the identification of new cases of diabetes and renal disorders.
Fresenius Medical Care AG & Co. KGaA, Baxter, DaVita Inc, and NIPRO Medical Corporation are some of the key players of the hemodialysis and peritoneal dialysis industry. According to data published by these renowned participants, hemodialysis dominates the market as of 2015 and is anticipated to maintain its dominance over the forecast period.
U.S. hemodialysis and peritoneal dialysis market, by product, 2014-2025 (USD Million)
On the other hand, Baxter is attempting to increase the revenue share for peritoneal dialysis owing to its application in home-care settings. Other strategic initiatives being undertaken by the players are increasing the number of treatment centers in lucrative geographies, increasing awareness level amongst patients & general public and forming tie-ups with public and private insurance providers to promote the sale of their products.
In addition, a driver anticipated to vitally impact the industry over the forecast period is the rising inclination of patients toward home-based treatments. Automation of the processes along with development of small-size machines that promote flexibility to patients is expected to boost the market sales over the forecast period
Dialysis is performed on patients suffering from kidney disorders such as renal failure. The augmenting rise in incidence of such conditions is expected to propel the growth. On the basis of type, treatment maybe performed by two techniques namely hemodialysis and peritoneal dialysis. As of 2015, hemodialysis is expected to dominate the market. It is also anticipated to maintain its dominance over the forecast period growing with CAGR of over 5.0%.
However, peritoneal dialysis is also expected to witness lucrative growth owing to rising demand for the services amongst neonates and children. Furthermore, higher applicability of this technique in home-based services is another factor promoting the growth of the segment.
In April 2015, Baxter received CE mark approval for introducing HOMECHOICE CLARIA in the European market. This device is used for performing peritoneal dialysis in the comfort of home-based settings.
The report provides an in-depth analysis of the hemodialysis and peritoneal dialysis industry on the basis of product. The level one segmentation is inclusive of devices, consumables, and services. As of 2015, these services held majority of the shares. Development of new treatment centers and rapid growth in home-based services by competitors is expected to support growth over the forecast period. For instance, the services segment contributed for more than 67.0% of the total revenue generated by Fresenius Medical Care AG & Co. KGaA in 2015.
Devices have been further segmented into dialysis machines, dialyzers, water treatment systems, and other products. Similarly, consumables have also been further segmented into bloodlines, concentrates, catheters, and others.
On the basis of end-use, the market is classified into home-based and hospital-based. The hospital-based segment is inclusive of all the treatment centers established across the globe. According to an organization Global Dialysis, there are more than 17,000 centers in about 161 countries as of 2015. This number is further expected to increase over the forecast period.
For instance, Fresenius Medical Care AG & Co. KGaA announced the opening of eight new centers in collaboration with John Hopkins Hospital in 2017. These centers would be located in Baltimore, U.S. to meet the growing demand within the region.
Global hemodialysis and peritoneal dialysis market, by type, 2015
North America dominated the market as of 2015 by contributing over 35.0% of the revenue. The presence of a large number of centers and introduction of new products within the region is expected to support growth. As of 2015, more than 85.0% of the procedures performed are through hemodialysis across various centers and hospitals. U.S. is one of the leading regions for the early and larger adoption of this method.
Other regions that are expected to report lucrative growth over the forecast period include Germany, India, Japan, Mexico, Saudi Arabia, and South Africa. Asia Pacific region is likely to grow at the fastest rate over the forecast period owing to rising incidences of kidney failure and lower rate of organ transplantation.
The report elucidates various industry participants that offer a wide portfolio of products catering to the dialysis treatment. These include Fresenius Medical Care AG & Co. KGaA, B.Braun Avitum AG, NIPRO Medical Corporation, DaVita Inc., Baxter, and others.
To promote growth, these players are promoting innovation and research within the field. For instance, in November 2015, Fresenius Medical Care AG & Co. KGaA announced the opening of China Design Center, their R&D center, which is focused on making developments and innovations in the field of renal care. Furthermore, the center aims at producing cost-effective products in order to gain a higher market share in China.
Base year for estimation
Actual estimates/Historical data
2014 - 2015
2016 - 2025
Revenue in USD Million and CAGR from 2016 to 2025
North America, Europe, Asia Pacific, Latin America & MEA
U.S., Canada, UK, Germany, Japan, China, India, Brazil, Mexico
Revenue forecast, company share, competitive landscape, growth factors and trends
15% free customization scope (equivalent to 5 analyst working days)
If you need specific market information, which is not currently within the scope of the report, we will provide it to you as a part of customization
Segments Covered in the Report
This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the hemodialysis and peritoneal dialysis market on the basis of type, product, end-use and region:
Type Outlook (Revenue, USD Million, 2014 - 2025)
Short daily hemodialysis
Continuous Ambulatory Peritoneal Dialysis (CAPD)
Automated Peritoneal Dialysis (APD)
Product Outlook (Revenue, USD Million, 2014 - 2025)
Water treatment system
End-use Outlook (Revenue, USD Million, 2014 - 2025)
Regional Outlook (Revenue, USD Million, 2014 - 2025)
Middle East and Africa (MEA)
Avail customized purchase options to meet your research needs:
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.